Wardwizard Healthcare has successfully completed the preferential allotment of 1,08,70,000 convertible warrants, raising an immediate Rs 2.72 crore as upfront payment. The total value of the issuance stands at Rs 10.87 crore, with 17 allottees participating, including promoter Yatin Sanjay Gupte. Each warrant allows conversion into equity within 18 months, representing a strategic capital infusion for the company.
Wardwizard Healthcare Completes Preferential Allotment of Convertible Warrants
1,08,70,000 warrants allotted at Rs 10 per share.
Rs 2.72 crore received as initial upfront capital infusion.
Reader Takeaway: Immediate capital inflow boosts liquidity, though long-term equity dilution remains a factor upon future warrant conversion.
What just happened
Wardwizard Healthcare Ltd has officially approved the allotment of 1,08,70,000 fully convertible warrants. This follows the approval granted by shareholders at the company's 42nd Annual General Meeting held on September 30, 2026. The company successfully collected the required 25% upfront payment, amounting to Rs 2,71,75,000, from a group of 17 investors.
Why this matters
The issuance provides the company with immediate working capital and growth funding. Each warrant grants the holder the right to subscribe to one equity share of face value Rs 10 at any time within the next 18 months. This structure balances immediate cash needs with a phased approach to equity expansion.
Changes in Issuance
The final issuance size was revised downward from an initially proposed 1,25,00,000 warrants to the current 1,08,70,000. This adjustment was necessitated by the withdrawal of Mr. Ilyashbhai Dhobi from the process and a reduced subscription commitment from promoter Mr. Yatin Sanjay Gupte, who adjusted his subscription from 52 lakh to 42 lakh warrants.
The Allottees
The allotment list spans both promoters and external investors. Key promoter participation includes Mr. Yatin Sanjay Gupte and Ms. Sheetal Mandar Bhalerao. The non-promoter group consists of 15 entities, including corporate houses such as P. B. Films Limited and Kayan Investment & Trading Company Private Limited.
What to track next
Investors should monitor the company's regulatory filings over the next 18 months to track the actual conversion of these warrants into equity. Additionally, the specific deployment of the Rs 2.72 crore upfront capital will be a key performance indicator in upcoming quarterly reports.